COGT
Cogent Biosciences, Inc.
$39.97
-0.04 (-0.10%)
At close · Jul 8
Market Cap
$6.92B
Shares
170,868,004
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-06-11 | 2026-06-09 | |
| 8-K | 2026-05-05 | — | |
| 10-Q | 2026-05-05 | 2026-03-31 | |
| DEF 14A | 2026-04-23 | 2026-06-09 | |
| 8-K | 2026-02-17 | — | |
| 10-K | 2026-02-17 | 2025-12-31 | |
| 8-K | 2025-12-08 | 2025-12-06 | |
| 8-K | 2025-11-18 | — | |
| 8-K | 2025-11-13 | 2025-11-11 | |
| 8-K | 2025-11-10 | — | |
| 10-Q | 2025-11-07 | 2025-09-30 | |
| 8-K | 2025-11-03 | — | |
| 8-K | 2025-09-11 | 2025-09-05 | |
| 8-K | 2025-08-05 | — | |
| 10-Q | 2025-08-05 | 2025-06-30 | |
| 8-K | 2025-07-10 | 2025-07-07 | |
| 8-K | 2025-07-07 | — | |
| 8-K | 2025-06-11 | — | |
| 8-K | 2025-06-05 | 2025-06-04 | |
| 10-Q | 2025-05-06 | 2025-03-31 | |
| 8-K | 2025-05-06 | — | |
| DEF 14A | 2025-04-22 | 2025-06-04 | |
| 10-K | 2025-02-25 | 2024-12-31 | |
| 8-K | 2025-02-25 | — | |
| 8-K | 2024-12-09 | 2024-12-08 | |
| 8-K | 2024-11-12 | — | |
| 10-Q | 2024-11-12 | 2024-09-30 | |
| 8-K | 2024-09-03 | — | |
| 8-K | 2024-08-06 | — | |
| 10-Q | 2024-08-06 | 2024-06-30 | |
| 8-K | 2024-06-27 | — | |
| 8-K | 2024-06-05 | — | |
| 10-Q | 2024-05-07 | 2024-03-31 | |
| 8-K | 2024-05-07 | — | |
| DEF 14A | 2024-04-23 | 2024-06-05 | |
| 8-K | 2024-03-22 | 2024-03-21 | |
| 8-K | 2024-02-26 | — | |
| 10-K | 2024-02-26 | 2023-12-31 | |
| 8-K | 2024-02-14 | 2024-02-13 | |
| 8-K | 2023-12-11 | 2023-12-09 | |
| 10-Q | 2023-11-07 | 2023-09-30 | |
| 8-K | 2023-11-02 | — | |
| 8-K | 2023-08-08 | — | |
| 10-Q | 2023-08-08 | 2023-06-30 | |
| 8-K | 2023-06-08 | 2023-06-06 | |
| 8-K | 2023-06-07 | — | |
| 8-K | 2023-06-06 | 2023-06-03 | |
| 8-K | 2023-05-09 | — | |
| 10-Q | 2023-05-09 | 2023-03-31 |
Showing 1–50 of 110 filings